Skip to main content
Clinical Trials/NCT05441085
NCT05441085CompletedNot Applicable

Programmed Intermittent Epidural Bolus Interval 90 Min of 10ml,0.0625% Bupivacaine Plus 2μg/mL Fentanyl in Nulliparous Versus Multiparous Parturient

Menoufia University2 sites in 1 country30 target enrollmentStarted: November 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
adequate labour analgesia

Study Overview

Brief Summary

Multiple studies showed the numerous advantages of implementing programmed epidural bolus (PIEB) technique, where a fixed volume of local anesthetic is automatically administrated at a set time interval compared to the continuous epidural infusion technique (CEI). The advantages were improved maternal satisfaction, decreased local anesthetic consumption, and decreased second stage of labor.The theory behind PIEB is that to attain a more uniform spread of local anesthetic in the epidural space a higher volume of injectate and a higher pressure is needed.Different approaches using different timings and volumes for PIEB have been proposed to achieve the optimal regimen. Many studies showed evidence that 10 mL boluses of bupivacaine 0.0625% with fentanyl 2 μg/mL delivered every 40 min, named effective programed intermittent epidural bolus interval 90 (EI90), produced effective analgesia without breakthrough pain in 90% of nulliparous women during the first stage of labor.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
— to 50 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients of ASA physical status 2-3 with a singleton pregnancy
  • •gestational age > 37 weeks
  • •regular uterine contractions occurring at least every 5 min;
  • •cervical dilation 2-5 cm
  • •pain > 5 (Visual analogue score (VAS) 0-10) at the time of request for epidural analgesia .

Exclusion Criteria

  • •Refusal to concent
  • •Contraindication to epidural analgesia as allergy or hypersensitivity to bupivacaine or fentanyl
  • •Patients who had opioids or sedatives within 4 h preceding epidural insertion.
  • •Unintentional dural puncture.
  • •Patient who deliver within 1 h after initiation of epidural clinician bolus.
  • •The inability to achieve as VAS score ≤2 after the initial loading dose will be considered as a failure and will be excluded from the study.

Arms & Interventions

Nulliparous

Active Comparator

Patients of ASA physical status 2-3 with a singleton pregnancy; gestational age > 37 weeks; regular uterine contractions occurring at least every 5 min; cervical dilation 2-5 cm; and pain > 5

Intervention: programed intermittent epidural bolus interval 90 (EI90) (Device)

Multiparous

Active Comparator

Patients of ASA physical status 2-3 with a singleton pregnancy; gestational age > 37 weeks; regular uterine contractions occurring at least every 5 min; cervical dilation 2-5 cm; and pain > 5

Intervention: programed intermittent epidural bolus interval 90 (EI90) (Device)

Outcomes

Primary Outcomes

adequate labour analgesia

Time Frame: six hours

Time of first call for bolus dose of epidural After loading dose

Secondary Outcomes

  • Upper sensory block(24hours)
  • Side effects(24 hours)
  • Motor block(24 hours)
  • Total anaesthetic volume(24 hours)
  • Visual Analogue Scale to pain(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

rabab Mohammad habeeb

Principal investigator

Menoufia University

Study Sites (2)

Loading locations...

Similar Trials